Profil bibliographique

M L Conteh

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

6Publications signalées

220Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Viral Infections and Outbreaks ResearchVaccine Coverage and HesitancySARS-CoV-2 and COVID-19 ResearchBacillus and Francisella bacterial researchCoronary Interventions and Diagnostics

Publications récentes

Accès ouvert 2026 article

Long-term safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen: a cohort study of previously vaccinated adults and children in Sierra Leone (the EBOVAC-Salone extension study)

Daniela Manno, Ahmed Dahiru Balami, Agnes Bangura, A Kamara et autres

0 citationsThe Lancet Regional Health - Africa

Accès ouvert 2025 article

Binding Affinity Is Not Binding Behavior: Reframing Learned Molecular Recognition around Kinetics, Conformational Change, and Residence Time

Binta Jallow, M L Conteh, Christopher Okafor, Fatou Sanyang

0 citationsPharmacophore

Accès ouvert 2024 article

Refractory prinzmetal variant angina successfully managed with prazosin: a case report

A Hearn, M L Conteh, Fahad Khan, Vishal Patel et autres

0 citationsThe American Journal of the Medical Sciences

Accès ouvert 2022 article

Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial

Daniela Manno, Agnes Bangura, Frank Baiden, A Kamara et autres

26 citationsThe Lancet Infectious Diseases

Accès ouvert 2021 article

Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial

Muhammed O. Afolabi, David Ishola, Daniela Manno, Babajide Keshinro et autres

98 citationsThe Lancet Infectious Diseases

Accès ouvert 2021 article

Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial

David Ishola, Daniela Manno, Muhammed O. Afolabi, Babajide Keshinro et autres

96 citationsThe Lancet Infectious Diseases

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.